Market Snapshot:
Scalp cooling caps are used to providing cold temperatures to scalp during treatment of chemotheraphy for cancer. Scalp Cooling Caps market is expected to mark significant growth over forecasted period owing to increasing cancer patients, providing limiting blood flow and technological advancement. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the scalp cooling systems.
Highlights from Scalp Cooling Caps Market Study
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
High Growth Market | Asia Pacific |
Largest Market | North America |
Unit | Value (USD Million) |
The key Players profiled in the report are Paxman Scalp Cooling (United Kingdom), Penguin Cold Caps (United States), Chemotherapy Cold Caps (United States), Dignitana (Sweden) and Medline Industries (United States).
Geographic Breakdown and Segment Analysis
The Global Scalp Cooling Caps market presents a comprehensive analysis of the Scalp Cooling Caps market by product type (Chemo Cold Caps and Nomal Cold Caps), by end-user/application (Chemotherapy Induced Hair Loss, Neonatal Encephalopathy, Cardiac Arrest and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Scalp Cooling Caps industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the North America holds majority of market share of the Scalp Cooling Caps market, the Europe has emerged as a crucial market for several Scalp Cooling Caps brands.
Analyst at AMA have segmented the market study of Global Scalp Cooling Caps market by Type, Application and Region.
Influencing Trend:
Increase in prevalence of cardiac arrhythmia boost the scalp coolingg caps. and Collaboration and Tie Up Of Leading Players
Market Growth Drivers:
Increase prevalence of cardiac arrhythmia Boost the Scalp cooling caps Market. and Concerns of doctors towards scalp cooling caps Fuelled up The Market.
Challenges:
Limitation on the government rules and regulation are Anticipated the Challenge the Market. and Sophisticated Programming In Graphic Processors Hampers the Global Market.
Restraints:
Cancer Cells present in hair hampers the Scalp cooling caps Market. and Lack of awareness among customers.
Opportunities:
Availability products in E-commerce Leads to Grow the Scalp cooling Caps Market. and Upsurge Demand of Scalp cooling Caps in Asia-pacific region.
In March 2019, Paxman launched a hair loss prevention product for cancer patients which is beneficial in providing cold caps which reduce the scalp temperature during chemotherapy, and as a result reduce and prevent hair loss.
Regulatory Insights:
“According to Food and Drug Administration (FDA), its approved the scalp cooling caps, that has cleared a cooling cap—a device designed to reduce hair loss during chemotherapy—for use by patients with any kind of solid tumor. FDA initially cleared the device, the DigniCap Scalp Cooling System, for patients with breast cancer in 2015.”
Key Target Audience
Scalp cooling Caps Manufacturers, Scalp cooling Caps Traders, End-Use Market Participants of Different Segments of Scalp cooling Caps, Government and Research Organizations, R&D Institutions and Others